Expert Outlook: Pacific Biosciences Through The Eyes Of 10 Analysts

Pacific Biosciences (NASDAQ:PACB) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The table below summarizes their recent ratings, sho

Benzinga14:00 ET

Stocks With More Than 10% Short Interest - Finviz Screener

Seeking Alpha13:07 ET

Scotiabank Sticks to Its Buy Rating for Pacific Biosciences (PACB)

TipRanksMay 13 11:26 ET

Pacific Biosciences Is Maintained at Neutral by Piper Sandler

Pacific Biosciences Is Maintained at Neutral by Piper Sandler

Dow JonesMay 13 09:07 ET

Express News | Piper Sandler Maintains Neutral on Pacific Biosciences, Lowers Price Target to $2

BenzingaMay 13 08:57 ET

The Pacific Biosciences of California, Inc. (NASDAQ:PACB) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Pacific Biosciences of California, Inc. (NASDAQ:PACB) just released its latest first-quarter report and things are not looking great. The numbers were fairly weak, with revenue of US$39m missing

Simply Wall StMay 11 08:25 ET